Form 4: Gilead Sciences SVP, Controllership Sandra Patterson Reports Stock Transactions
SEC Form 4 Filing
Sandra Patterson, SVP, Controllership at Gilead Sciences, reports the vesting and disposal of restricted stock units and shares acquired through the employee stock purchase plan.
Summary
- Sandra Patterson, SVP, Controllership at Gilead Sciences, reported transactions involving the company's common stock on March 10, 2025.
- These transactions included the vesting of 1,952 restricted stock units, which were then converted into common stock.
- Additionally, 624 shares were disposed of at a price of $117.21.
- Following these transactions, Patterson directly owns 39,453 shares of Gilead Sciences common stock and 9,875 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency into the trading activities of company executives.
Stakeholder Impact
- The transactions reported may have a minor impact on shareholders due to the change in ownership of shares.
Key Dates
| Date | Description |
|---|---|
| 03/10/2025 | Date of stock transactions (vesting of restricted stock units and disposal of shares). |
| 03/12/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.